API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
The API team and investigators will work together to design and develop small molecule therapeutics to fight the current and the future variants of coronavirus….
API joins the Edmonton delegation for the San Francisco Trade Mission
Andrew MacIsaac, CEO and Director, API visited San Francisco as part of the Edmonton, Alberta delegation for the San Francisco-Edmonton business and tourism trade mission….
Read Moreabout API joins the Edmonton delegation for the San Francisco Trade Mission
API partners with a University of Saskatchewan scientist to discover and develop novel antivirals against emerging Coronavirus variants
Forming an academic-industry collaboration, the project will combine virology expertise of Dr. Anil Kumar, University of Saskatchewan with API’s expertise in drug development to identify…
API participates in ‘Transformations in Health Technologies’ panel at the Alberta Technology Symposium
Micheal Guirguis, Director, Clinical Pharmacology & Data and member of API’s senior leadership team visited Calgary this week to be a part of the Alberta…
API joins the Edmonton delegation for the Nashville Business & Tourism Trade Mission
Members of API’s senior leadership team Hana Marinkovic, Director of Corporate Affairs and Micheal Guirguis, Director, Clinical Pharmacology & Data visited Nashville as part of the…
Read Moreabout API joins the Edmonton delegation for the Nashville Business & Tourism Trade Mission
Applied Pharmaceutical Innovation (API) announces establishment of team with researchers from Nova Scotia Universities for antiviral drug discovery against SARS-CoV-2 and RNA viruses
Through this academic and industry collaboration, the partners will create a rich training environment for students and postdoctoral fellows, strengthen antiviral drug discovery pipeline against…
Nobel Laureate and member of API Scientific Advisory Committee, Dr. Michael Houghton recognized in the Alberta Bioindustry Hall of Fame
Edmonton, AB. March 22, 2022: We’re thrilled to announce that BioAlberta has recognized Nobel Laureate and member of API Scientific Advisory Committee, Dr. Michael Houghton in…
Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program
The Pfizer Applied Clinical Pharmacology Program is a multi-year program created by Applied Pharmaceutical Innovation (API) in partnership with the Faculty of Pharmacy and Pharmaceutical Sciences…
Home-Grown Talent: Brian Corrigan, Global Head, Clinical Pharmacology, Pfizer and member of API’s Scientific Advisory Committee
Brian Corrigan, Vice President and Global Head of Clinical Pharmacology, and Head of Clinical Pharmacology for Global Product Development at Pfizer in Groton, Connecticut, sat…
Micheal Guirguis, Director, Clinical and Data Services: Why Is Drug Development Important?
In this video, Micheal Guirguis, Director, Clinical and Data Services at API shares why working in the Life Sciences and drug development is important to…
API joins the Canadian Chamber of Commerce-Member network and the Life Sciences Strategy Council
Applied Pharmaceutical Innovation (API) announced that it is formally a member of the Canadian Chamber of Commerce and will join the ‘Life Sciences Strategy Council’…
Govt of Alberta announces of ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working Group
Today, the Government of Alberta announced a new working group ‘The Edmonton Metro Region Economic Recovery (EMRER)’ that will engage with local leaders and residents…
Archana Koul, Scientist, API: Interacting with the life sciences industry
In this video, Archana Koul, Scientist (S1) shares her experience of working with API as a post-doctoral fellow, and how this experience allowed her to…
Read Moreabout Archana Koul, Scientist, API: Interacting with the life sciences industry
Canurta Inc. announces partnership with Applied Pharmaceutical Innovation (API) and Dr. Neal M. Davies of University of Alberta for novel hemp polyphenols-based drug discoveries
Canurta Inc., the pioneering company behind patent-pending hemp technologies and formulations that targets inflammation at the source has formed a multi-year strategic partnership with Applied…
Inviting all start-up entrepreneurs and innovators seeking to raise $1 million in seed-stage funding – Life Sciences Investment Summit 2022
The Startup TNT Life Sciences Investment Summit is a unique platform created in partnership between Applied Pharmaceutical Innovation and Startup TNT to empower innovative ideas,…
The Government of Alberta announces $5.6 million in funding to Applied Pharmaceutical Innovation for the Canadian Critical Drug Initiative (CCDI)
https://www.youtube.com/watch?v=mL50WS_7rIg December 01, 2021: Today, the Government of Alberta announced funding to strengthen Alberta’s life sciences and pharmaceutical sector. We are excited to share that…
